Development of innovative emerging radiopharmaceuticals

The innovative emerging radiopharmaceuticals are used in the diagnosis and treatment of various diseases, primarily cancer, but also neurological disorders and cardiovascular diseases. Some key areas of innovation in this field are:

- Targeted Radionucleide Therapy (Radioligand Therapy)

- Theranostics: A Combination of Therapy and Diagnostics

- Radionuclide Production and Novel Isotopes

- Artificial Intelligence (AI) and Machine Learning in Radiopharmaceutical Development

- Improved Drug Delivery Systems

While the progress in radiopharmaceutical development is promising, several challenges remain:

Regulatory hurdles: Ensuring that radiopharmaceuticals meet safety standards and are approved by regulatory bodies like the EMA.

Manufacturing and cost: The production of radiopharmaceuticals requires specialized facilities and can be costly, particularly for short-lived isotopes.

Patient access: Delivering cutting-edge treatments to patients globally, particularly in regions with limited healthcare infrastructure.